Koninklijke Philips NV vs ProShares UltraPro Short QQQ ETF — how do they compare? Koninklijke Philips NV trades at $25.02 (market cap $24.61B), while ProShares UltraPro Short QQQ ETF trades at $39.03. The key difference: Koninklijke Philips NV pays a 4.05% dividend while ProShares UltraPro Short QQQ ETF pays none. Which is the better fit depends on your goals.
| PHG | SQQQ | |
|---|---|---|
Market Cap | $24.61B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $32.91 | $89.43 |
52-Week Low | $25.02 | $36.04 |
Enterprise Value | $31.21B | — |
Dividend Yield | 4.05% | — |
Signals from Pluang's Aura AI — not financial advice
PHG trades at $25.29, down 2.32% today, with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with Q2 2026 EPS of $0.57 beating expectations of $0.40, and positive net income of $895M in 2025 reversing previous losses. Recent product launches in women's health and AI-powered medical devices demonstrate innovation momentum.
The outlook is mixed with strong fundamentals and analyst support (36% buy ratings) offset by technical weakness. Key opportunities include margin expansion and new product adoption, while risks involve cybersecurity threats and competitive pressures in healthcare technology.
SQQQ, a 3x leveraged inverse ETF tracking the Nasdaq-100, trades at $38.31, up 0.34% on the day. Technical indicators are bearish with moving averages signaling sell, while oscillators remain neutral. The ETF is designed for short-term hedging against tech declines but faces structural erosion from daily resets, as highlighted by Seeking Alpha on 2026-06-26. Recent news suggests tactical use amid AI-driven market volatility, but long-term holding risks severe losses.
Outlook: SQQQ offers tactical downside protection in bearish tech markets but is unsuitable for long-term investment due to leverage decay. Risks include rapid value erosion and high volatility, requiring precise timing. Opportunities exist for hedging QQQ exposure during corrections, but investors must monitor Nasdaq-100 trends closely to avoid capital depletion.
Trailing returns across standard periods
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →SQQQ is a leveraged inverse ETF that seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the Nasdaq-100 Index. It is a tactical trading tool designed for sophisticated investors to profit from or hedge against declines in large-cap technology and growth stocks. Due to its daily reset and the effects of compounding, it is intended for short-term use and carries significant risk if held during periods of high market volatility.
Read more on SQQQ →